ABVC

ABVC BioPharma (ABVC)

ABVC BioPharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ABVC

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/19	22:30	GlobeNewswire Inc.	ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21	NASDAQ:ABVC	ABVC BioPharma Inc
2024/12/11	20:30	GlobeNewswire Inc.	ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners	NASDAQ:ABVC	ABVC BioPharma Inc
2024/11/16	05:31	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:ABVC	ABVC BioPharma Inc
2024/11/16	05:30	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:ABVC	ABVC BioPharma Inc
2024/11/16	05:28	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:ABVC	ABVC BioPharma Inc
2024/11/16	05:26	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:ABVC	ABVC BioPharma Inc
2024/11/15	09:33	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:ABVC	ABVC BioPharma Inc
2024/11/14	23:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABVC	ABVC BioPharma Inc
2024/11/14	23:00	GlobeNewswire Inc.	ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones	NASDAQ:ABVC	ABVC BioPharma Inc
2024/11/14	22:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ABVC	ABVC BioPharma Inc
2024/11/05	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABVC	ABVC BioPharma Inc
2024/10/26	01:21	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:ABVC	ABVC BioPharma Inc
2024/10/22	21:45	GlobeNewswire Inc.	ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners	NASDAQ:ABVC	ABVC BioPharma Inc
2024/10/19	06:23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABVC	ABVC BioPharma Inc
2024/09/11	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABVC	ABVC BioPharma Inc
2024/08/21	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABVC	ABVC BioPharma Inc
2024/08/17	05:31	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:ABVC	ABVC BioPharma Inc
2024/08/17	05:30	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:ABVC	ABVC BioPharma Inc
2024/08/17	05:30	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:ABVC	ABVC BioPharma Inc
2024/08/15	20:30	GlobeNewswire Inc.	ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements	NASDAQ:ABVC	ABVC BioPharma Inc
2024/08/15	20:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABVC	ABVC BioPharma Inc
2024/08/15	04:18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ABVC	ABVC BioPharma Inc
2024/08/08	06:15	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ABVC	ABVC BioPharma Inc
2024/08/02	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ABVC	ABVC BioPharma Inc
2024/07/27	05:30	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:ABVC	ABVC BioPharma Inc
2024/07/24	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABVC	ABVC BioPharma Inc
2024/07/13	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABVC	ABVC BioPharma Inc
2024/07/13	05:00	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:ABVC	ABVC BioPharma Inc
2024/05/24	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABVC	ABVC BioPharma Inc
2024/05/24	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABVC	ABVC BioPharma Inc